Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis
Cancer Treatment Reviews · 2024-12 · 131 · 102833
DOI: 10.1016/j.ctrv.2024.102833 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Treatment Reviews, 2024-12. Verfasst von Riona Aburaki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Yokohama City University School of Medicine, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Neoadjuvant Therapy, Lung Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Yokohama City University School of Medicine, Japan.
- Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo NY USA; Department of Clinical Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Elect…
- Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
- Chemotherapy Center, Yokohama City University Hospital, Japan.
- Division of Hematology and Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA, USA.
Zitieren
APA
Aburaki, R., Fujiwara, Y., Chida, K., Horita, N., & Nagasaka, M. (2024). Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis. Cancer Treatment Reviews, 131, 102833. https://doi.org/10.1016/j.ctrv.2024.102833
Vancouver
Aburaki R, Fujiwara Y, Chida K, Horita N, Nagasaka M. Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis. Cancer Treatment Reviews. 2024;131:102833. doi:10.1016/j.ctrv.2024.102833
BibTeX
@article{Aburaki2024,
author = {Aburaki, Riona and Fujiwara, Yu and Chida, Kohei and Horita, Nobuyuki and Nagasaka, Misako},
title = {Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis},
journal = {Cancer Treatment Reviews},
year = {2024},
volume = {131},
pages = {102833},
doi = {10.1016/j.ctrv.2024.102833}
}
EUVIMED